WMT has been acquired by Soleal Unternehmerkapital AG
The private shareholders of WMT S.r.l. have sold the company to Soleal Unternehmerkapital AG.
WMT is specialized in the processing of plastic materials on behalf of third parties and provides its customers with a global service, ranging from design and construction of molds to molding, with the possibility of subsequent assembly. All production is in Italy, at the plants located in Seriate and Cologno al Serio and is intended for both the national and international markets. WMT’s products and services are mainly addressed to the coffee industry (molds for coffee machines and coffee pods), white goods and sports equipment.
Soleal invests solely and exclusively the capital of its two founders, Karl Spielberger and Fabrice Nava. It buys majority stakes in SMEs in Switzerland, Germany, Austria and Italy, with the aim to further develop these companies with a long-term perspective.
Oaklins’ team in Italy acted as the exclusive financial advisor to the shareholders of WMT in the entry into its capital of the investment holding company Soleal Unternehmerkapital AG
Talk to the deal team
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more